Profile

Contact Details

Email: karyn.maclennan@otago.ac.nz

University Links

Position: Research Fellow
Research summary: Safe and optimal use of medicines, medicines communication, Māori health, health equity

Research

Karyn has a background in pharmacology and psychology, has worked broadly across pharmaceutical medicine in New Zealand and the UK and is a member of the Pharmacoepidemiology Research Network Core Academic Group.

She has a strong interest in public outreach and communication about medicines, Māori health, health inequities, and partnering with community groups to collaborate on locally relevant research projects. Her current research includes:

Interactive public outreach about the science of medicines, which aims to empower children and their whānau to have confident discussions and make informed, shared, and positive decisions about medicines
A participatory science project with Cystic Fibrosis Otago investigating safe disposal of antibiotic residue in nebulisers
Exploring the supportive care needs of Māori cancer survivors
Exploring whānau acceptability of CovidCard contact tracing technology in the Ngongotahā CovidCard trial

Publications

Maclennan, K. (2023, August). Community conversations: The science of medicines: Whakatere Waka. Verbal presentation at the 33rd Queenstown Molecular Biology Meeting (QMB), Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Bateman, J., Egan, R., & Maclennan, K. (2023). 'Survivorship care is one big gap': A qualitative study of post-treatment supportive care in Aotearoa New Zealand. BMC Health Services Research, 23, 594. doi: 10.1186/s12913-023-09580-8 Journal - Research Article

Maclennan, K. (2022). Reaching our rangatahi: Creating conversations about medicines and going viral with a D-Bug game design challenge. Proceedings of the 7th Pharmacoepidemiology Research Network Symposium. (pp. 7). Retrieved from https://www.otago.ac.nz/pharmacoepidemiology Conference Contribution - Published proceedings: Abstract

Chambers, T., Egan, R., Maclennan, K., Emery, T., & Derrett, S. (2022). Expert insights on digital contact tracing: interviews with contact tracing policy professionals in New Zealand. Health Promotion International. doi: 10.1093/heapro/daac059 Journal - Research Article

Maclennan, K. (2021). Engaging communities in conversations about COVID-19, vaccines, and community immunity. Proceedings of the 6th Pharmacoepidemiology Research Network Symposium. (pp. 8-9). Retrieved from https://www.otago.ac.nz/pharmacoepidemiology Conference Contribution - Published proceedings: Abstract

2023

Journal - Research Article

Conference Contribution - Verbal presentation and other Conference outputs

Maclennan, K. (2023, August). Community conversations: The science of medicines: Whakatere Waka. Verbal presentation at the 33rd Queenstown Molecular Biology Meeting (QMB), Queenstown, New Zealand.

2022

Journal - Research Article

Conference Contribution - Published proceedings: Abstract

2021

Journal - Research Article

Parkin, L., Maclennan, K., Te Morenga, L., Inder, M., & Moata'ane, L. (2021). What helps and hinders metformin adherence and persistence: A qualitative study exploring the views of people with type 2 diabetes. New Zealand Medical Journal, 134(1536), 25-40. Retrieved from https://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

2019

Conference Contribution - Published proceedings: Abstract

Maclennan, K., Parkin, L., Te Morenga, L., Sopoaga, F., Inder, M., & Moata'ane, L. (2019). What helps and hinders metformin adherence and persistence: Views of people with type 2 diabetes. Proceedings of the 5th Pharmacoepidemiology Research Network Symposium. Retrieved from https://www.otago.ac.nz/pharmacoepidemiology

2016

Journal - Research Article

Maclennan, K., Brounéus, F., & Parkin, L. (2016). Public knowledge and desire for knowledge about drug safety issues: A survey of the general public in New Zealand. Pharmaceutical Medicine, 30(6), 339-348. doi: 10.1007/s40290-016-0164-4

2012

Journal - Research Article

Brounéus, F., Macleod, G., Maclennan, K., Parkin, L., & Paul, C. (2012). Drug safety awareness in New Zealand: Public knowledge and preferred sources for information. Journal of Primary Health Care, 4(4), 288-293.

2011

Working Paper; Discussion Paper; Technical Report

Brounéus, F., Maclennan, K., Parkin, L., Paul, C., for the University of Otago Pharmacovigilance Research Team. (2011). Communicating drug safety information to health care professionals and the public. Health Research Council of New Zealand, and Medsafe. Dunedin, New Zealand: University of Otago. 52p.

2003

Journal - Research Article

Maclennan, K. M., Zheng, Y., Sheard, P. W., Williams, S. M., Darlington, C. L., & Smith, P. F. (2003). Adrenalectomy-induced cell death in the dentate gyrus: Further characterisation using TUNEL and effects of the Ginkgo biloba extract, EGb 761 and ginkgolide B. Hippocampus, 13, 212-225.

2002

Journal - Research Article

Maclennan, K. M., Darlington, C. L., & Smith, P. F. (2002). The CNS effects of Ginkgo biloba extracts and ginkgolide B. Progress in Neurobiology, 67, 235-257.

1999

Chapter in Book - Research

Darlington, C. L., Smith, P. F., & Maclennan, K. M. (1999). The neuroprotective properties of ginkgo extracts. In T. A. Van Beek (Ed.), Medicinal and Aromatic Plants - Industrial Profiles: Ginkgo Biloba. (pp. 331-344). Amsterdam: Harwood Academic Publishers.

Journal - Research Article

Smith, P. F., & Maclennan, K. M. (1999). The neuroprotective effects of platelet activating factor (PAF) receptor antagonists in CNS disorders. Current Opinion in Anti-inflammatory & Immunomodulatory Investigational Drugs, 1, 205-218.

1998

Journal - Research Article

Paul, C. A., Sansom, A. J., Maclennan, K., Darlington, C. L., & Smith, P. F. (1998). The effects of steroids on vestibular compensation and vestibular nucleus neuronal activity in guinea pig. Journal of Vestibular Research, 8(3), 201-207.

Journal - Research Other

Maclennan, K., Smith, P. F., & Darlington, C. L. (1998). Adrenalectomy-induced neuronal degeneration. Progress in Neurobiology, 54, 481-498. doi: 10.1016/S0301-0082(97)00076-2

1997

Chapter in Book - Research

Darlington, C. L., Smith, P. F., & Maclennan, K. M. (1997). Effects of Ginkgo biloba extract (EGb 761) on recovery from peripheral vestibular deafferentation (vestibular compensation). In V. Papadopoulos, K. Drieu & Y. Christen (Eds.), Advances in Ginkgo biloba Research, Vol. 6. (pp. 47-58). Paris: Elsevier.

1996

Journal - Research Article

Maclennan, K., Smith, P. F., & Darlington, C. L. M. (1996). The effects of ginkgolide B (BN52021) on guinea pig vestibular nucleus neurons in vitro: importance of controlling for effects of dimethylsulphoxide (DMSO) vehicles. Neuroscience Research, 26(4), 395-399.

Maclennan, K. M., Smith, P. F., & Darlington, C. L. (1996). Platelet-activating factor in the CNS. Progress in Neurobiology, 50(5-6), 585-596.

1995

Journal - Research Article

Smith, P. F., Darlington, C. L., & Maclennan, K. (1995). Ginko Biloba: An ancient Chinese tree with neuroprotective properties. Asia Pacific Journal of Pharmacology, 10, 3-4.